Stemness of Human Wharton's Jelly Mesenchymal Cells Is Maintained by Floating Cultivation

被引:13
作者
Higuchi, Osamu [1 ,2 ]
Okabe, Motonori [1 ]
Yoshida, Toshiko [1 ]
Fathy, Moustafa [1 ,4 ]
Saito, Shigeru [3 ]
Miyawaki, Toshio [2 ]
Nikaido, Toshio [1 ]
机构
[1] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300914, Japan
[2] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 9300914, Japan
[3] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Obstet & Gynecol, Toyama 9300914, Japan
[4] Menia Univ, Dept Biochem, Fac Pharm, Al Minya 002086, Egypt
关键词
HUMAN UMBILICAL-CORD; IN-VITRO; HUMAN PLACENTA; STROMAL CELLS; BLOOD; FETAL; DIFFERENTIATION; TRANSPLANTATION; REGENERATION; VIABILITY;
D O I
10.1089/cell.2012.0020
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Recently, the search for stem cells has become focused on fetal appendages such as the amniotic membrane and umbilical cord. Previously, we have shown the existence of stem cells in the amniotic membrane that can differentiate into various cells. In this study, we attempt to characterize and maintain the stemness characteristics of mesenchymal stem cells (MSCs) for Wharton's jelly, an inherent tissue of the umbilical cord. Wharton's jelly cells (WJCs) were isolated, adhered to culture plates, and characterized for stem cell and surface markers expression. They expressed the embryonic stem cell markers Nanog, Oct 3/4, and Sox2. On flow cytometric analysis, WJCs predominantly expressed the MSC markers CD73, CD90, and CD105 and did not express the hematopoietic lineage markers CD14, CD34, CD45, and HLA-DR. In floating culture, WJCs could maintain stemness, and they could differentiate to osteogenic, chondrogenic, and adipogenic lineages. In conclusion, WJCs satisfy the criteria of MSCs. Given that extraction of the umbilical cord is not invasive, and the umbilical cord can be obtained without ethical and technical issues, we suggest that WJCs, after maintaining stemness, have a potential contribution to medical treatment for patients, even newborns, with congenital skeletal and cartilage disorders.
引用
收藏
页码:448 / 455
页数:8
相关论文
共 50 条
  • [1] VITRIFICATION OF HUMAN UMBILICAL CORD WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS
    Massood, Ezzatabadipour
    Maryam, Kaviani
    Parvin, Salehinejad
    Mojgan, Mohammadi
    Noureddin, Nematollahi-Mahani Seyed
    CRYOLETTERS, 2013, 34 (05) : 471 - 480
  • [2] Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration
    Leow, S. N.
    Luu, Chi D.
    Nizam, M. H. Hairul
    Mok, P. L.
    Ruhaslizan, R.
    Wong, H. S.
    Halim, Wan Haslina Wan Abdul
    Ng, M. H.
    Ruszymah, B. H. I.
    Chowdhury, S. R.
    Bastion, M. L. C.
    Then, K. Y.
    PLOS ONE, 2015, 10 (06):
  • [3] Mesenchymal Stem Cells from the Wharton's Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential
    Marino, Luigi
    Castaldi, Maria Antonietta
    Rosamilio, Rosa
    Ragni, Enrico
    Vitolo, Rosa
    Fulgione, Caterina
    Castaldi, Salvatore Giovanni
    Serio, Bianca
    Bianco, Rosario
    Guida, Maurizio
    Selleri, Carmine
    INTERNATIONAL JOURNAL OF STEM CELLS, 2019, 12 (02) : 218 - 226
  • [4] Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture
    Drela, Katarzyna
    Lech, Wioletta
    Figiel-Dabrowska, Anna
    Zychowicz, Marzena
    Mikula, Michal
    Sarnowska, Anna
    Domanska-Janik, Krystyna
    CYTOTHERAPY, 2016, 18 (04) : 497 - 509
  • [5] Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells
    Datta, Indrani
    Mishra, Swati
    Mohanty, Lipsa
    Pulikkot, Sunitha
    Joshi, Preeti G.
    CYTOTHERAPY, 2011, 13 (08) : 918 - 932
  • [6] A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy
    El-Demerdash, Rasha F.
    Hammad, Lamiaa N.
    Kamal, Mohamed M.
    El Mesallamy, Hala O.
    REGENERATIVE MEDICINE, 2015, 10 (07) : 841 - 855
  • [7] Wharton's Jelly Derived Mesenchymal Stem Cells: Comparing Human and Horse
    Merlo, Barbara
    Teti, Gabriella
    Mazzotti, Eleonora
    Ingra, Laura
    Salvatore, Viviana
    Buzzi, Marina
    Cerqueni, Giorgia
    Dicarlo, Manuela
    Lanci, Aliai
    Castagnetti, Carolina
    Iacono, Eleonora
    STEM CELL REVIEWS AND REPORTS, 2018, 14 (04) : 574 - 584
  • [8] Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
    Hu, Ying
    Liang, Jun
    Cui, Hongping
    Wang, Xinmei
    Rong, Hua
    Shao, Bin
    Cui, Hao
    NEURAL REGENERATION RESEARCH, 2013, 8 (19) : 1783 - 1792
  • [9] Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid
    Joerger-Messerli, Marianne S.
    Marx, Caterina
    Oppliger, Byron
    Mueller, Martin
    Surbek, Daniel V.
    Schoeberlein, Andreina
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2016, 31 : 30 - 44
  • [10] Isolation and Characterization of Feline Wharton's Jelly-Derived Mesenchymal Stem Cells
    Seo, Min-Soo
    Kang, Kyung-Ku
    Oh, Se-Kyung
    Sung, Soo-Eun
    Kim, Kil-Soo
    Kwon, Young-Sam
    Yun, Sungho
    VETERINARY SCIENCES, 2021, 8 (02) : 1 - 13